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The potential prostate cancer susceptibility gene ELAC2 has a Caenorhabditis elegans homolog (which we call hoe-1, for h
¯
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¯
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LAC2). We have explored the biological role of this gene using RNAi to reduce gene activity. We found that worms subjected to hoe-1
RNAi are slow-growing and sterile. The sterility results from a drastic reduction in germline proliferation and cell-cycle arrest of germline
nuclei. We found that hoe-1 is required for hyperproliferation phenotypes seen with mutations in three different genes, suggesting hoe-1 may
be generally required for germline proliferation. We also found that reduction of hoe-1 by RNAi suppresses the multivulva (Muv) phenotype
resulting from activating mutations in ras and that this suppression is likely to be indirect. This is the first demonstration of a biological role
for this class of proteins in a complex eukaryote and adds important information when considering the role of ELAC2 in prostate cancer.
D 2003 Elsevier Inc. All rights reserved.Keywords: C. elegans; Germline; Prostate cancer; hoe-1Introduction
In the United States, it is estimated that over 30,000 men
die each year from prostate cancer (Greenlee et al., 2000).
Prostate cancer is a complex disease with a documented
familial component. This has led to an intensive effort to
uncover possible prostate cancer susceptibility loci in the
human genome. At least 16 loci have been reported to
harbor prostate cancer susceptibility genes (reviewed in
Peters and Ostrander, 2001; Simard et al., 2002). However,
the definitive data identifying all the genes and linking any
of these loci to prostate cancer are still lacking.
The prostate cancer susceptibility gene HPC2/ELAC2 on
chromosome 17 was identified 2 years ago by Tavtigian et
al. (2001). They performed a genome-wide scan of 127
high-risk prostate cancer families from the Utah Population
Database, followed by positional cloning and mutational
mapping. This led Tavtigian et al. (2001) to the gene they
called ELAC2, which harbored either a frameshift or a
missense mutation that segregated with prostate cancer in0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.10.016
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unfamiliar but contains a well-conserved histidine motif
domain found in metal-dependent hydrolases. This domain
is also similar to regions present in PSO2, a DNA inter-
strand cross-link repair protein and in a subunit of CPSF73,
an mRNA 3Vend cleavage and polyadenylation specificity
factor. The interstrand cross-link repair function is particu-
larly interesting given the known relationship of DNA repair
activities to cancer (Patel et al., 1998). However, to date,
there has been no demonstration of any of these biochemical
activities associated with this protein. So, while the data
linking ELAC2 to prostate cancer are tantalizing, the bio-
logical role of this protein and its link to cancer remain
elusive.
The nematode Caenorhabditis elegans contains a homo-
log to ELAC2, termed E04A4.4 (Tavtigian et al., 2001).
While only 26% identical overall, the worm and human
protein share considerable identity (50%) in the histidine
motif domains described above. This model organism
provides an excellent means to explore the biological role
of the ELAC2 homolog, which we have named hoe-1
(h
¯
omolog o
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f E
¯
LAC2). Many genes implicated in human
disease have counterparts in C. elegans. Moreover, several
genes implicated in human cancers, such as ras, p53, and
Rb, have well-defined worm homologs, so ample prece-
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worm (Beitel et al., 1990; Derry et al., 2001; Han and
Sternberg, 1990; Lu and Horvitz, 1998). The determination
of the biological role of the worm homolog of ELAC2 could
lend credence to the notion that ELAC2 is indeed a prostate
cancer susceptibility gene.
We have explored the biological role of the worm
homolog of ELAC2, and have found that it plays an
important and general role in germline proliferation. We
have also demonstrated that hoe-1 has effects on phenotypes
resulting from activating ras mutations, though these effects
appear to be indirect. Our work supports a role for hoe-1 in
cell division in C. elegans and is the first demonstration of
any biological role for the ELAC2 class of proteins.Materials and methods
Genetics
The following C. elegans mutations were used in this
study. LG I: gld-1(q485), mek-2(n1989), glp-4(bn2); LG II:
let-23(sa62); LG III: glp-1(e2141), glp-1(oz112), glp-
1(q231), cul-1(e1765), lin-12(n950), glp-3(q145); LG IV:
let-60(sy93), let-60(n2021), let-60(n1046), let-60(ga89), lin-
45(ku112), lin-1(e1275); LG X: lin-15(n765). All strains
were cultured at 20jC according to standard procedures
(Brenner, 1974) unless otherwise noted.
RNAi
Double-stranded RNA corresponding to hoe-1 was tran-
scribed from PCR products derived from the yk39c9 cDNA
clone (kindly provided by Yuji Kohara) using the RNA
transcription kit from Stratagene. RNAs were purified using
a Qiagen RNAeasy column. Sense and antisense strands
were annealed at 37jC for 30 min. dsRNAwas injected into
young adults, which were transferred to fresh plates daily
for 3 days following injection. The progeny of the injected
animals were scored for mutant phenotypes. Alternatively,
the yk39c9 cDNA was cloned into the feeding vector
pPD129.36 (Timmons and Fire, 1998) and transformed into
HT115 (DE3) bacterial cells as described (Timmons et al.,
2001). Various stage animals, depending on the experiment,
were placed on feeding plates and their progeny were
observed for phenotypes.
5VRACE
To confirm/identify the 5V end of the hoe-1 message,
we performed 5V RACE using the 5VRACE System for
Rapid Amplification of cDNA Ends, version 2.0, from
GIBCO. Briefly, first-strand cDNA was synthesized from
total RNA using one of three primers: E04R400 CGA-
CGCTTGAACTTCGGATCC, EO4R800 ACTTGAT-
CAGGTTGAATCGTC, or EO4RT ACAATTGAGTTGG-CCGGTGG. First-strand cDNA was then PCR-amplified
in two or three rounds of nested PCR. 5Vprimers for PCR
included GIBCO 5V RACE Abridged Anchor Primer, or
trans-spliced leader SL1 or SL2 (Huang and Hirsh, 1989;
Krause and Hirsh, 1987). 3V PCR primers included
EO4A43VR1 GACGAATGCTTCTGAAGAATTCGGC-
GAT, EO4A4Xho GCTTGCGTTTACTTCTCGAGC-
TTTCA, EO4R400, and EO4RT. Race products were
cloned into the pCRII vector (Invitrogen) and sequenced.
In addition, we fully sequenced the EST clones yk39c9
and yk42h12.
Quantitative real-time PCR
A synchronized population of adult wild-type animals or
glp-1(e2141ts) animals was obtained by selecting for eggs
from a mixed population of worms by hypochlorite treat-
ment. Eggs were plated and animals grown to the adult stage
at 25jC. Animals were harvested and total RNA was
isolated using the Trizol reagent (Molecular Research Cen-
ter, Inc.). For experiments with glp-1(oz112), 50–100 unc-
32(e189) glp-1(oz112), adult animals that segregated from
an unc-32(e189) glp-1(oz112)/unc-36(e251) glp-1(q175)
heterozygous parent were transferred to an Eppendorf tube
containing M9 buffer. After a rinse to remove unwanted
bacteria, RNA was extracted using the Trizol reagent. From
such preparations, we could recover in the range of 50–500
ng of total RNA. For comparison in these experiments, N2
young adult worms were treated in parallel with the glp-
1(oz112) animals. To ensure that the samples were not
contaminated with genomic DNA, all total RNAwas treated
with DNAse for 1 h at 37jC. RNAwas then purified over an
RNAeasy column (Qiagen).
For quantitative real-time PCR, 100 ng of total RNA/well
was reverse-transcribed to cDNA using the Platinum Quan-
titative RT-PCR Thermoscript One-Step System (Invitrogen)
in a reaction volume of 25 Al. Quantitative real-time PCR
was performed in an ABI GeneAmp 5700 Sequence Detec-
tor. Efficiency of amplification for each set of primers was
determined by a standard curve using either a plasmid or
PCR fragment (both corresponding to cDNA sequence) of
the gene being amplified. All samples were normalized to an
actin control. For each combination of RNA and primer/
probe pair, four replicates were performed and the results
were averaged.Results
Identification of the hoe-1 cDNA
To understand the role of hoe-1, we first isolated and
sequenced cDNAs corresponding to the C. elegans ortholog
(E04A4.4) identified by Tavtigian et al. (2001). Initially, the
clone yk39c9 was the longest EST available from the
sequencing consortium (Y. Kohara, personal communica-
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appear to be full length, we performed 5VRACE and RT-
PCR. Many C. elegans messages are transpliced to a 22-
nucleotide leader sequence termed SL1 or SL2 (Huang and
Hirsh, 1989; Krause and Hirsh, 1987). To aid in our
identification of 5Vend products, we used three different 5V
primers—SL1 and SL2 in RT-PCR reactions, and an unbi-
ased primer that should enable us to capture all 5Vends of
the cDNA regardless of sequence for RACE (see Materials
and methods for details). Products from the three reactions
were cloned into a plasmid vector. A total of 19 clones were
sequenced and their sequence organization is summarized in
Fig. 1.
E04A4.4 appears to be alternatively spliced and has the
potential to encode at least three proteins, which we term
E04A4.4 A, B, or C. E04A4.4A encodes the longest
protein and the cDNA can be trans-spliced to either SL1
or SL2. Recently, a new EST corresponding to E04A4.4A
was added to the database (yk896c4; Y. Kohara, personal
communication), which is transpliced to SL2. The
E04A4.4B cDNA is as long as E04A4.4A, but contains
either 5 or 10 additional bases downstream from the first
ATG. Both of these variants include an in-frame stop
codon. Therefore, the first ATG in this class of cDNA is
in exon 3. The last class of cDNA, E04A4.4C, is trans-
pliced to SL1 and begins at the start of exon 2; the first in-
frame ATG in these molecules is also the ATG in exon 3.
This sequencing predicts a slightly different protein thanFig. 1. (A) Schematic representation of the results of RT-PCR analysis of hoe-1. Th
by boxes and introns by diagonal lines. The red and blue introns in EO4A4.4 B in
The number of clones containing either the SL1 or SL2 trans-spliced leader is indi
amplified using a generic 5Vprimer that allows capture of any 5Vend. 2/2 EO4A4.4A
5Vprimer. (B) Predicted protein sequence of the different splice variants. We show
to utilize the methionine indicated by the bold, black M, and EO4A4.4B and EOoriginally identified by Genefinder (www.wormbase.org).
The actual 5Vend lies further upstream than the first ATG
in the predicted exon 1; the predicted first exon was not
found in any cDNA species we analyzed.
CeELAC2 RNAi results in sterility
To investigate the role of hoe-1 in C. elegans, we
performed RNAi (RNA interference). RNAi is a widely
used technique where dsRNA molecules are delivered to
adult animals by microinjection, soaking, or feeding (Fire et
al., 1998; Tabara et al., 1998; Timmons and Fire, 1998), and
the progeny are examined for abnormalities. Treatment of
animals in this way is a well-documented method to assess
reduction-of-function phenotypes. We employed both mi-
croinjection and feeding with identical results.
Progeny of L4 or young adult wild-type worms subjected
to hoe-1 RNAi grow slowly and are sterile. It takes these
animals approximately 5–6 days to reach adulthood, which
is in contrast to the 3.5 days it takes untreated animals to
become adults. To determine if these animals are generally
slow-growing throughout the larval stages or if particular
stages of development were slowed, we followed individual
progeny of animals grown on hoe-1 dsRNA feeding plates
from eggs that had just been laid until the adult stage. We
followed wild-type animals grown on the HT115 bacteria
carrying the vector alone as a comparison. Wild-type eggs
and eggs from hoe-1 RNAi-treated L4 animals hatch at thee three different splice variants are indicated graphically. Exons are indicated
dicate the two different variants isolated; the exact sequence is shown in B.
cated to the right. 1/4 EO4A4.4A clones that contained SL1 were originally
clones that contained SL2 were originally amplified with the same generic
the DNA sequence for the 5Vend of all splice forms. EO4A4.4A is predicted
4A4.C are predicted to utilize the methionine indicated in green.
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including P cell migration, M cell division, the first intes-
tinal cell division, seam cell division, and the L1 molt, and
found no difference between wild type (n = 10) and progeny
of hoe-1 RNAi-treated animals (n = 10). For the L2 stage,
we examined the time at which the gonad primordium
formed, the presence of dorsal ceolomocytes, and the L2
molt and again found no differences between wild type (n =
8) and progeny of hoe-1 RNAi-treated animals (n = 11). In
contrast, progression through the L3 and L4 stages were
significantly slowed in hoe-1 RNAi-treated animals, though
the extent to which each larval stage was slowed was highly
variable.
Furthermore, the germ line in these animals fails to
properly proliferate (Fig. 2). In wild-type hermaphrodite
animals, the gonad consists of two reflexed tubes and has
a somatic and germline component. The germ line begins
to proliferate from the germline precursor cells Z2 and Z3
midway through the first larval stage. This proliferation
continues through the four larval stages so that an adult
hermaphrodite generates about 1000 cells per side (Kimble
and Hirsh, 1979). In hoe-1 RNAi-treated animals, the adult
hermaphrodites have approximately 64.8 (n = 10) germline
cells per side, as determined by DAPI staining. In addi-
tion, no gametes are generated. However, the somaticFig. 2. Nomarski micrographs of hoe-1 RNAi-treated animals. In all pictures, post
wild-type animals were treated with hoe-1 dsRNA, and the proliferation of the ge
marker. In all cases, we show just the posterior arm of the gonad but the anterio
Animals subjected to hoe-1 RNAi. The white arrow in all panels indicates the di
gonad can reflex normally, but there are many fewer nuclei present. For example,
the picture, while if fits readily in panel F.gonad seems normal in these animals. For example, the
gonad migrates properly, which is a function of the
somatic distal tip cell (Kimble and White, 1981). The
uterus and the spermatheca also have appropriate cell
numbers and morphology.
When we subject L2 animals to hoe-1 RNAi, we observe
a more severe phenotype among their progeny. F1 progeny
become adults only after 8 days or more, but again pro-
gression through the embryonic, L1, and L2 stages happens
normally. Germline proliferation is even more severely
affected with an average of 14 (n = 9) germ cells per side.
We also observe a new defect. In the VPCs, we see some
animals (3/24) in which a VPC has two nucleoli. We have
observed this phenotype in VPCs themselves (Pn.p cells) or
progeny of VPCs (Pn.px cells). This phenotype was also
observed in the evl-20 mutant and was postulated to be
indicative of a failed cell division (Antoshechkin and Han,
2002).
Consistent with a role in germline development, we can
demonstrate that the hoe-1 message is enriched in the germ
line. We have been unable to obtain transgenic lines con-
taining a hoe-1 promoterDGFP fusion, even at very low
concentrations of plasmid, or when included in complex
arrays. Presumably, this DNA fragment is somehow toxic
for the animal, so we have been unable to determine theerior is to the right, ventral is down. Magnification is 630 in all cases. L4
rm line was assessed using the stage of vulval cell divisions as a temporal
r arm looks comparable. (A, C, E) Untreated wild-type animals. (B, D, F)
stal end of the growing germ line. In the hoe-1 RNAi-treated animals, the
in panel E, the entire posterior arm of the gonad does not fit in the frame of
Fig. 3. Quantitative real-time PCR analysis of hoe-1 levels in the germ line.
One hundred nanograms of total RNA isolated from animals with genotype
indicated on the horizontal axis was analyzed using quantitative, real-time
PCR (TaqMan). Molecules of hoe-1 per/100 ng of total RNA was
determined by comparison to a standard curve generated from a PCR
fragment of hoe-1. In addition, all samples were normalized against an actin
control. Each gray bar represents the average of four independent replicates,
with the standard error indicated.
Fig. 4. DAPI staining of hoe-1 RNAi-treated animals. (A) Untreated adult.
(B) hoe-1 RNAi-treated adult animal. Both panels are 1000 magnifica-
tion. The arrow points to a mitotic figure in a germ-line cell where the
chromosomes are aligned at the metaphase plate. In panel B, no such
figures are found. Most nuclei have the phenotype indicated by the
arrowheads, where the chromosomes appear to be partially condensed. This
kind of morphology is also seen in wild type, so these nuclei appear to
arrest at a naturally occurring stage of the cell cycle.
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assess whether hoe-1 is expressed in the germ line, we
performed quantitative, real-time PCR analysis using RNA
derived from adult wild-type worms, adult glp-1(e2141ts)
mutant worms, which do not produce a germ line when
grown at restrictive temperature, and adult glp-1(oz112)
animals, which have a tumorous germline phenotype where
germ cells never leave the mitotic cell cycle (Berry et al.,
1997). If hoe-1 is expressed in the germ line, we expect to
see less hoe-1 message in the glp-1(e2141ts) sample of
RNA. Indeed, we observe approximately two times more
hoe-1 mRNA in wild-type worms relative to glp-1(e2141ts)
mutant worms (Fig. 3; see Materials and methods for
details). In a complementary experiment, we assessed the
level of hoe-1 expression when the germ line overprolifer-
ates. Quantitative real-time PCR analysis of the quantity of
hoe-1 mRNA in adult glp-1(oz112) animals revealed a
threefold to fourfold increase as compared to wild-type
adults (Fig. 3). Thus, the level of hoe-1 mRNA roughly
correlates with the extent of proliferation of the germ line.
To gain further insight into the severe reduction of
germline proliferation in hoe-1 RNAi-treated worms, we
examined the nuclear morphology of germline cells in
DAPI-stained animals. The germline cells appear to have
a fairly uniform morphology with partly condensed chro-
mosomes that have not yet aligned at the metaphase plate,
suggesting a prometaphase arrest (Fig. 4). This phenotype is
similar to what has been described for the genes glp-3
(Kadyk et al., 1997) and glp-4 (Beanan and Strome,
1992). It has been suggested that both these genes are
necessary for the mitotic cell cycle in the germ line.
However, we did not observe any synthetic phenotypes
when glp-4(bn2) or glp-3(q145) animals were subjected to
hoe-1 RNAi (data not shown). glp-3(q145) animals have a
very strong germline proliferation defect so it may not bepossible to detect a more severe phenotype indicative of an
interaction with hoe-1, especially if the role of either gene is
limited to the germ line. glp-4(bn2) animals were not shifted
to the restrictive temperature until the L3 stage, at which
point they produce about 70 germ nuclei (Beanan and
Strome, 1992); thus, a more severe phenotype of these
animals in conjunction with hoe-1 RNAi would be readily
detectable. Since neither experiment revealed new pheno-
types, is not clear whether hoe-1 functions in the same
process as either of these genes.
We also wanted to determine if hoe-1 plays a role in
meiosis. As stated earlier, hoe-1 RNAi-treated animals
produce no gametes so hoe-1 is possibly required for
progression through mitosis and meiosis. The distal tip cells
in the somatic gonad are known to promote mitosis through
the GLP-1/Notch receptor. In animals where the distal tip
cells are ablated or that have loss-of-function mutations in
Table 1
Effect of hoe-1 RNAi on let-60(ras) phenotypes
dsRNA let-60 allele Phenotype (n)
None n1046 (gf) 74.5% Muv (277)
hoe-1 n1046 (gf) 0% Muv (119)
None ga89 (gf) 25.3% Muv (324)
hoe-1 ga89 (gf) 0% Muv (216)
None sy93 (dn) 5.3% L1 lethal (169);
88.6 % Vul, 11.4% Muv (44)
hoe-1 sy93 (dn) 5.2% L1 lethal (77);
88.6% Vul, 11.4% Muv (35)
None n2021 (lf) 79.2% L1 lethal (221);
20.1% Vul (34)
hoe-1 n2021 (lf) 92.9% L1 lethal (157);
23.1% Vul (26)
Mutant L4 animals were either injected with dsRNA or placed on bacteria
expressing dsRNA (results were identical using the two methods of dsRNA
delivery). Progeny were scored after 5–6 days at 20jC. All progeny were
sterile as are the progeny of wild-type worms when treated with this
dsRNA. Since all let-60 mutant animals are also sterile when subjected to
hoe-1 RNAi, we scored the Vul phenotype of viable let-60(n2021) and let-
60(sy93) animals using Nomarski optics. We examined L4 or adult animals
for the presence of vulval induction.
Table 2
hoe-1 RNAi does not affect phenotypes associated with other VPC signal
transduction genes
dsRNA Gene (allele) Phenotype (n)
None let-23(sa62) 97.1% Muv (103)
hoe-1 let-23(sa62) 91.8% Muv (171)
None lin-45(ku112) 0 (93)
hoe-1 lin-45(ku122) 0 (22)a
None mek-2(n1989) 15.6% Vul,
4.5% L1 lethal (199)
hoe-1 mek-2(n1989) 3.3% Vulb,
5.1% L1 lethal (97)
None lin-15(n765) 100% Muv (164)
hoe-1 lin-15(n765) 100% Muv (135)
None lin-1(e1275) 100% Muv (111)
hoe-1 lin-1(e1275) 100% Muv (57)
None lin-12(n950) 100% Muv (176)
hoe-1 lin-12(n950) 100% Muv (112)
Mutant L4 animals were either injected with dsRNA or placed on bacteria
expressing dsRNA (results were identical using the two methods of dsRNA
delivery). Progeny were scored after 5–6 days at 20jC, except for the lin-
1(e1275) and lin-15(n765) strains, which were grown at 25jC. All progeny
were sterile as are the progeny of wild-type worms when treated with this
dsRNA.
a Because these animals are sterile, the presence of a vulva could not be
ascertained by an egg-laying assay. Therefore, 22 animals were scored for
the presence of a vulva using Nomarski optics; 22/22 had a vulva. No other
phenotypes, like larval lethality, were observed.
b Because these animals are sterile, the presence of a vulva could not be
ascertained by an egg-laying assay. Therefore, the 93 viable animals were
scored for the presence of a vulva using Nomarski optics; 90/93 had a
vulva.
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ically to form sperm (Austin and Kimble, 1987). glp-
1(q231ts) animals raised at the permissive temperature
(15jC) have normal germ lines. However, glp-1(q231)
animals shifted to the restrictive temperature during the L1
stage cease germline mitosis; all germ cells enter meiosis
and differentiate as sperm (n = 44 this work; Austin and
Kimble, 1987). We treated glp-1(q231) animals with hoe-1
dsRNA at 15jC and then shifted the L1 progeny to
restrictive temperature. We found that 100% of the shifted
animals (n = 54) failed to make sperm. We performed the
same experiment with L4 animals. glp-1(q231) animals
shifted to restrictive temperature during the L4 stage were
able to produce both sperm and oocytes (n = 72). However,
when L4 progeny of glp-1(q231) animals treated with hoe-1
dsRNA were shifted to restrictive temperature, 94.6% pro-
duced no gametes (n = 75); a small percentage produced a
few sperm. Thus, it seems that the majority of hoe-1 RNAi
animals are unable to undergo meiosis.
hoe-1 RNAi suppresses an activated ras phenotype
The human homolog of hoe-1 has been postulated to
play a role in cancer (Tavtigian et al., 2001). Since many
cancers result from the oncogene ras being inappropriately
activated, we looked for genetic interactions between hoe-1
and let-60 ras. The let-60 allele n1046 is a G13D mutation
that results in constitutive ras activity; let-60(n1046)
animals display a multivulva (Muv) phenotype (Beitel et
al., 1990; Han and Sternberg, 1990). In wild-type animals,
three out of six VPCs respond to an inductive signal and
undergo three rounds of cell division. In mutants where
let-60 ras is constitutively activated, all six VPCs undergo
three rounds of cell division leading to the formation of
ectopic pseudovulva and the Muv phenotype. let-60(n1046) animals treated with hoe-1 dsRNA give rise
to 100% non-Muv animals (Table 1). We performed
lineage analysis of the VPCs on let-60(n1046) animals
subjected to hoe-1 RNAi. Five out of five animals
exhibited a wild-type pattern of cell division. Thus, the
suppression is likely to be occurring at the level of cell fate
determination, and is not the result of morphogenesis
defects. This suppression is not restricted to the let-
60(n1046) allele. The let-60(ga89ts) lesion results in a
L19F change that results in a Muv phenotype (Eisenmann
and Kim, 1997); the Muv phenotype of these animals is
also suppressed by hoe-1 RNAi (Table 1). However, we
found no effect on ras phenotypes (L1 lethality and vulval
induction) associated with the dominant-negative allele
sy93 or the hypomorphic allele n2021. These results
suggest that hoe-1 RNAi does not reduce ras activity in
general.
We next wanted to examine the effect of hoe-1 RNAi on
the Muv phenotype resulting from mutations in other genes
in this well-defined developmental pathway centered around
ras activity. Mutations in the let-23 receptor tyrosine kinase
and the lin-1 ETS transcription factor result in animals with
a Muv phenotype (Beitel et al., 1995; Clark et al., 1994;
Greenwald et al., 1983; Huang et al., 1994; Katz et al.,
1996). hoe-1 RNAi did not suppress the Muv phenotype in
either of these genetic backgrounds (Table 2). Furthermore,
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hypomorphic alleles of lin-45 Raf or mek-2 MAP kinase
kinase. Gain-of-function mutations in the lin-12/Notch re-
ceptor and loss-of-function mutations in lin-15, a novel
protein, similarly result in a Muv phenotype. While these
genes regulate vulval development and are influenced by
activity of the ras pathway, they are not themselves mem-
bers of the canonical ras-mediated signal transduction
pathway. Again, the Muv phenotype of these animals is
unaffected by treatment with hoe-1 dsRNA (Table 2). Taken
together, these data suggest that hoe-1 is not an intrinsic
member of the canonical ras pathway. Since the wild-type
role of hoe-1 appears to be in regulating progression of the
cell-cycle, the suppression of the let-60Muv phenotype may
be explained if VPCs in this mutant background are more
sensitive to loss of hoe-1 than VPCs where ras itself is not
constitutively activated.
hoe-1 suppresses overproliferation in the germ line
Our experiments with hoe-1 RNAi indicate that germline
proliferation is most sensitive to reduction in hoe-1 activity.
This could be because the germ line is more responsive to
RNAi in general, or could reflect the fact that the germ line
is undergoing the most proliferation of any postembryonic
cell lineage. To test whether hoe-1 was generally requiredFig. 5. Nomarski micrographs of germline hyperproliferation mutants treated with h
side of the gonad is shown, but in all cases the other side was comparable. hoe-1
The genotype is indicated to the left of the photographs. RNAi-treated animals res
reduction in proliferation of the germ line—irrespective of the background genotfor mitotic cell division in the developing germ line, we
performed hoe-1 RNAi on three different mutants whose
germ line undergoes extensive overproliferation.
cul-1 is a member of a conserved family of proteins in
a pathway that targets proteins for destruction by ubiq-
uination (Kipreos et al., 1996). Mutations in cul-1 result
in hyperproliferation in many postembryonic blast cell
lineages including the vulva, the somatic gonad and the
germ line. cul-1(e1756) animals subjected to hoe-1 RNAi
have germ lines that fail to proliferate normally, just like
wild-type animals subjected to hoe-1 RNAi (Fig. 5).
However, the vulva and uterus still overproliferate in
these animals.
We also subjected glp-1(oz112) and gld-1(q485) mutant
animals to hoe-1 RNAi. The glp-1(oz112) mutation is a
dominant lesion in the GLP-1/Notch receptor that results in
a late-onset, tumorous germline phenotype (Berry et al.,
1997). The gld-1(q485) allele is a null allele in a KH
family RNA-binding protein (Jones et al., 1996); these
mutant animals contain germ cells in meiosis that revert to
mitotic proliferation and form germline tumors (Francis et
al., 1995a). Germline overproliferation in both glp-
1(oz112) and gld-1(q485) mutant animals was suppressed
by hoe-1 RNAi (Fig. 5). gld-1 and glp-1 have been shown
to interact genetically (Francis et al., 1995b) and hence
play roles, at least in part, in the same pathway. However,oe-1 dsRNA. Magnification is 630 in all cases; all animals are adults. One
RNAi-treated animals are on the left; the untreated animals are on the right.
embled wild-type animals treated with hoe-1 dsRNA (see Fig. 2)—a severe
ype.
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well-defined and how these genes interact to regulate
germline proliferation remains unknown. It seems likely
that hoe-1 acts downstream of these other three genes or in
an additional, parallel pathway, and suggests that hoe-1
may play a more general role in regulating cell division in
the germ line.Discussion
We have shown that reduction in hoe-1 activity by RNAi
results in slow-growing, sterile animals. Specifically, we
have demonstrated that this gene is required for germ cells
to progress through mitosis. Loss of this gene results in
animals with severely underproliferated germ lines. We have
also shown that hoe-1 RNAi suppresses the Muv phenotype
resulting from two different activating mutations in let-60
ras. Since hoe-1 RNAi has no effect on other members of
the well-defined ras pathway involved in vulval develop-
ment, we surmise that the effect on activated ras phenotypes
is indirect. Finally, we demonstrated that hoe-1 is required
for the germline overproliferation phenotypes observed in
certain cul-1, glp-1, and gld-1 alleles.
hoe-1 may be required for both mitosis and meiosis in
the germ line. hoe-1 dsRNA-treated animals produce no
gametes. We showed that even when we force all mitotic
cells into meiosis by genetically removing glp-1, the ma-
jority of animals fail to produce any gametes. The small
percentage that do produce sperm could be attributed to
incomplete penetrance of this defect. However, it is also
possible that hoe-1 only plays a role in mitosis and the germ
cells arrest at a point that makes them unable to enter
meiosis. Analysis of hoe-1 protein localization during germ-
line development may help to distinguish between these
possibilities.
While we can definitively identify a role for hoe-1 in
germline proliferation, we cannot rule out the possibility
that hoe-1 also plays a role in other or all cell divisions
during development. If hoe-1 played a general role in
progressing cells through mitosis, we would expect to
observe an embryonic or larval lethal phenotype. It is
possible that hoe-1 RNAi only decreases, but does not
eliminate, gene activity and thus we do not observe the
most severe phenotypes. This is supported by the observa-
tion that the progeny of an L4 animal treated with hoe-1
dsRNA exhibit a less severe germline proliferation defect
than the progeny of an L2 animal treated in the same way.
Another possibility is that hoe-1 activity is partially redun-
dant with another protein that is active in the soma, but not
in the germ line. Hence, depletion of hoe-1 activity most
severely affects the germ line because no other gene can
compensate for its loss. If this were the case, the gene
replacing hoe-1 in the soma would have to be distantly
related—we could detect no significant homologs in the C.
elegans genome. All hoe-1 RNAi-treated animals are slow-growing, but we have not been able to define the cellular
basis for this phenotype. Given enough time, most hoe-1
dsRNA-treated animals do reach adulthood. However, the
fact that hoe-1 RNAi suppresses the Muv phenotype of
activated ras mutants and the observation of two nucleoli in
some VPCs suggest that hoe-1 also plays a role in VPC
division.
Why does hoe-1 RNAi suppress the Muv phenotype
resulting from two different activating mutations in ras, but
does not suppress the same phenotype resulting from
inappropriately reducing or activating other members of
this pathway? One clue comes from interactions with either
dominant-negative or hypomorphic ras mutants. If hoe-1
was a positive regulator of ras activity, acting at the level of
ras or a gene in the pathway, then reduction of hoe-1 activity
should reduce ras activity, regardless of the nature of the
mutation. However, we observe no effect on phenotypes
associated with other types of ras mutations. We speculate
that the cellular environment resulting from mutations that
activate ras itself is somehow different than the cellular
environment that results when factors upstream or down-
stream of ras are mutated. In these latter cases, while ras
may be inappropriately activated, the ras protein itself is
wild type. Examining the different readouts of activated ras
in the presence and absence of hoe-1 could begin to uncover
these differences.
While we have identified an important biological role for
hoe-1, the central question of whether the human ELAC2
gene is indeed a prostate cancer susceptibility locus remains
to be answered. A confounding piece of data presented here
is that reduction of hoe-1 prohibits germline cells from
progressing through mitosis. However, the phenotype one
would expect from loss of a tumor-susceptibility locus is
one of increased proliferation, and in the case of humans,
cancer. This argument all hinges on confirming that the
mutations in the human ELAC2 gene are loss-of-function
mutations. The frameshift mutation in ELAC2 lies within
the conserved histidine motif and is predicted to truncate the
last one-third of the protein. While this mutation seems
likely to result in a loss of activity, it is not unreasonable to
postulate a gain of activity if some important regulatory
component lies in the latter third of the protein. The
missense mutation in ELAC2 occurs in the C-terminus of
the protein. We have been unable to discern the nature of
these mutations in our system. Overexpression of hoe-1
from its own promoter is toxic to worms, based on the
inability to generate transgenic lines. When the wild-type
hoe-1 gene or a variant bearing a missense mutation is
expressed from a heterologous promoter such as the heat-
shock promoter, no phenotypes were noted. As a side note,
we also expressed hoe-1 from the lin-31 promoter, which is
expressed in the vulva and other tissues (Miller et al., 1993),
but also found no reproducible overexpression phenotypes
(M. Smith and D. Levitan, unpublished observations). We
know that the germ line is particularly sensitive to changes
in hoe-1 levels, but it is also known that expression from
M.M. Smith, D.J. Levitan / Developmental Biology 266 (2004) 151–160 159transgene arrays is difficult in this tissue (Kelly et al., 1997;
Mello and Fire, 1995). Thus, this important issue is still
unresolved.
We have demonstrated the first biological role for the
ELAC2 class of proteins in eukaryotes. We have shown that
hoe-1 plays a role in germline proliferation by showing hoe-
1 RNAi-treated worms contain germ lines whose germ cells
arrest in prometaphase. This role is consistent with a role
governing cell proliferation in humans, though the specifics
of the process may be quite different in the two species. For
example, it is feasible for a protein to be a positive regulator
of a process in C. elegans and a negative regulator of a
process in humans. However, we acknowledge that the
biological role of hoe-1 in worms in no way confirms that
ELAC2 is a prostate cancer susceptibility gene in humans.
Regardless of whether hoe-1 is the worm homolog of a
prostate cancer susceptibility gene, it plays an important role
in the fundamental process of cell division and thus warrants
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